Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antithrombotic therapy in children.

W Streif1, L G Mitchell, M Andrew

  • 1Hamilton Civic Hospital Research Centre, Ontario, Canada.

Current Opinion in Pediatrics
|March 20, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leitlinie der Gesellschaft für Thrombose- und Hämostaseforschung (GTH) zur Struktur- und Prozessqualität von Hämophilie-Zentren.

Hamostaseologie·2024
Same author

Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.

Annals of hematology·2021
Same author

Identification of genetic modifiers of somatic CAG instability in Huntington's Disease by in vivo CRISPR - Cas9 genome editing: <b>PS238</b>.

Porto biomedical journal·2020
Same author

Validation of the Seegene RV15 multiplex PCR for the detection of influenza A subtypes and influenza B lineages during national influenza surveillance in hospitalized adults.

Journal of medical microbiology·2019
Same author

First Report of Alternaria Brown Spot of Citrus Caused by Alternaria alternata in Peru.

Plant disease·2019
Same author

[Pain therapy for children and adolescents with hemophilia : Recommendations by an expert panel].

Schmerz (Berlin, Germany)·2018
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Pediatric thromboembolic events are common but understudied. This review details antithrombotic agents for children, highlighting differences from adult treatments and guiding optimal use.

Area of Science:

  • Pediatric Hematology
  • Thrombosis and Hemostasis
  • Pharmacology

Background:

  • Thromboembolic events are a growing complication in children with severe illnesses.
  • Pediatric clinical trials for antithrombotic agents are limited due to event rarity.
  • Current pediatric treatment guidelines are often extrapolated from adult data.

Purpose of the Study:

  • To review antithrombotic agents used in pediatric thromboembolism.
  • To discuss mechanisms, dosing, monitoring, and side effects of these agents in children.
  • To address the need for pediatric-specific antithrombotic strategies.

Main Methods:

  • Literature review of antithrombotic agents in pediatric populations.
  • Analysis of standard heparin, low molecular heparin, and oral anticoagulants.

Related Experiment Videos

  • Evaluation of thrombolytic therapy, antiplatelet agents, antithrombin, and protein C concentrates.

    • Main Results:

    • Commonly used antithrombotic agents in children include heparin, LMWH, oral anticoagulants, thrombolytics, antiplatelets, antithrombin, and protein C concentrates.
    • Key aspects discussed: mechanisms, dosing, monitoring, therapeutic ranges, dose-response factors, and adverse effects.
    • Significant differences exist between pediatric and adult responses to antithrombotic therapy.

    Conclusions:

    • Optimal prevention and treatment of pediatric thromboembolism may differ from adult protocols.
    • Evidence-based guidelines tailored for children are crucial for effective antithrombotic therapy.
    • Further research is needed to establish pediatric-specific antithrombotic treatment strategies.